• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者的收缩压与心血管风险:一项前瞻性队列研究。

Systolic Blood Pressure and Cardiovascular Risk in Patients With Diabetes: A Prospective Cohort Study.

机构信息

Deep Medicine, Oxford Martin School, University of Oxford, Oxford, United Kingdom (S.R., Y.L., M.N., M.M., G.S.-K., K.R.).

Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom (S.R., Y.L., M.N., M.M., G.S.-K., K.R.).

出版信息

Hypertension. 2023 Mar;80(3):598-607. doi: 10.1161/HYPERTENSIONAHA.122.20489. Epub 2022 Dec 30.

DOI:10.1161/HYPERTENSIONAHA.122.20489
PMID:36583386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9944753/
Abstract

BACKGROUND

Whether the association between systolic blood pressure (SBP) and risk of cardiovascular disease is monotonic or whether there is a nadir of optimal blood pressure remains controversial. We investigated the association between SBP and cardiovascular events in patients with diabetes across the full spectrum of SBP.

METHODS

A cohort of 49 000 individuals with diabetes aged 50 to 90 years between 1990 and 2005 was identified from linked electronic health records in the United Kingdom. Associations between SBP and cardiovascular outcomes (ischemic heart disease, heart failure, stroke, and cardiovascular death) were analyzed using a deep learning approach.

RESULTS

Over a median follow-up of 7.3 years, 16 378 cardiovascular events were observed. The relationship between SBP and cardiovascular events followed a monotonic pattern, with the group with the lowest baseline SBP of <120 mm Hg exhibiting the lowest risk of cardiovascular events. In comparison to the reference group with the lowest SBP (<120 mm Hg), the adjusted risk ratio for cardiovascular disease was 1.03 (95% CI, 0.97-1.10) for SBP between 120 and 129 mm Hg, 1.05 (0.99-1.11) for SBP between 130 and 139 mm Hg, 1.08 (1.01-1.15) for SBP between 140 and 149 mm Hg, 1.12 (1.03-1.20) for SBP between 150 and 159 mm Hg, and 1.19 (1.09-1.28) for SBP ≥160 mm Hg.

CONCLUSIONS

Using deep learning modeling, we found a monotonic relationship between SBP and risk of cardiovascular outcomes in patients with diabetes, without evidence of a J-shaped relationship.

摘要

背景

收缩压(SBP)与心血管疾病风险之间的关联是单调的,还是存在最佳血压的低谷,这仍存在争议。我们研究了 SBP 全谱范围内糖尿病患者的 SBP 与心血管事件之间的关联。

方法

从英国的电子健康记录中确定了 1990 年至 2005 年间年龄在 50 至 90 岁之间的 49000 名糖尿病患者的队列。使用深度学习方法分析 SBP 与心血管结局(缺血性心脏病、心力衰竭、中风和心血管死亡)之间的关联。

结果

在中位随访 7.3 年期间,观察到 16378 例心血管事件。SBP 与心血管事件之间的关系呈单调模式,基线 SBP 最低的<120mmHg 组发生心血管事件的风险最低。与 SBP 最低的<120mmHg 的参考组相比,SBP 在 120-129mmHg 之间的心血管疾病风险比为 1.03(95%CI,0.97-1.10),SBP 在 130-139mmHg 之间的风险比为 1.05(0.99-1.11),SBP 在 140-149mmHg 之间的风险比为 1.08(1.01-1.15),SBP 在 150-159mmHg 之间的风险比为 1.12(1.03-1.20),SBP 在 160-169mmHg 之间的风险比为 1.19(1.09-1.28)。

结论

使用深度学习模型,我们发现糖尿病患者的 SBP 与心血管结局风险之间存在单调关系,没有 J 形关系的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65e/9944753/623985889c5a/hyp-80-598-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65e/9944753/543f08066dae/hyp-80-598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65e/9944753/1a57df1a8071/hyp-80-598-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65e/9944753/5d55944967a8/hyp-80-598-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65e/9944753/623985889c5a/hyp-80-598-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65e/9944753/543f08066dae/hyp-80-598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65e/9944753/1a57df1a8071/hyp-80-598-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65e/9944753/5d55944967a8/hyp-80-598-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65e/9944753/623985889c5a/hyp-80-598-g005.jpg

相似文献

1
Systolic Blood Pressure and Cardiovascular Risk in Patients With Diabetes: A Prospective Cohort Study.糖尿病患者的收缩压与心血管风险:一项前瞻性队列研究。
Hypertension. 2023 Mar;80(3):598-607. doi: 10.1161/HYPERTENSIONAHA.122.20489. Epub 2022 Dec 30.
2
Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk.收缩压、慢性阻塞性肺疾病与心血管风险。
Heart. 2023 Jul 27;109(16):1216-1222. doi: 10.1136/heartjnl-2023-322431.
3
Blood Pressure and Cardiovascular Disease in Older Patients With Diabetes: Retrospective Cohort Study.老年糖尿病患者的血压与心血管疾病:回顾性队列研究。
J Am Heart Assoc. 2021 Nov 16;10(22):e020999. doi: 10.1161/JAHA.121.020999. Epub 2021 Nov 2.
4
Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.糖尿病合并复发性心血管事件成人患者的高血压控制:西他列汀评估心血管结局试验的全球结果
Hypertension. 2017 Nov;70(5):907-914. doi: 10.1161/HYPERTENSIONAHA.117.09482. Epub 2017 Aug 28.
5
Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.患有高血压和新发心血管事件的成年人的收缩压水平:社区动脉粥样硬化风险研究
JAMA Intern Med. 2014 Aug;174(8):1252-61. doi: 10.1001/jamainternmed.2014.2482.
6
Potential Long-Term Benefit of Home Systolic Blood Pressure Below 125 mm Hg for Cardiovascular Risk Reduction: The J-HOP Study Extended.家庭收缩压低于 125mmHg 对降低心血管风险的潜在长期获益:J-HOP 研究的扩展。
Hypertension. 2024 Feb;81(2):282-290. doi: 10.1161/HYPERTENSIONAHA.123.22122. Epub 2023 Dec 11.
7
Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.2017 年美国心脏病学会/美国心脏协会血压指南中青年人群血压分类与日后心血管事件的关联。
JAMA. 2018 Nov 6;320(17):1774-1782. doi: 10.1001/jama.2018.13551.
8
Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Death in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.收缩压控制目标以预防 2 型糖尿病患者的主要心血管事件和死亡:系统评价和网络荟萃分析。
Hypertension. 2023 Aug;80(8):1640-1653. doi: 10.1161/HYPERTENSIONAHA.123.20954. Epub 2023 May 31.
9
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.在高危患者中实现血压和心血管结局:ONTARGET 和 TRANSCEND 试验结果。
Lancet. 2017 Jun 3;389(10085):2226-2237. doi: 10.1016/S0140-6736(17)30754-7. Epub 2017 Apr 5.
10
Orthostatic and Standing Hypertension and Risk of Cardiovascular Disease.直立性和站立性高血压与心血管疾病风险
Hypertension. 2025 Feb;82(2):382-392. doi: 10.1161/HYPERTENSIONAHA.124.23409. Epub 2024 Dec 5.

引用本文的文献

1
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice.《2024年欧洲高血压指南:临床实践关键建议比较》
Nat Rev Cardiol. 2025 Jul 21. doi: 10.1038/s41569-025-01187-2.
2
Interaction and combined effect of triglyceride-glucose index and hypertension on type 2 diabetes individuals' peripheral arterial disease risk.甘油三酯-葡萄糖指数与高血压对2型糖尿病患者外周动脉疾病风险的相互作用及联合效应
Acta Diabetol. 2024 Oct 26. doi: 10.1007/s00592-024-02391-1.
3
Effectiveness of a nurse-led management intervention on systolic blood pressure among type 2 diabetes patients in Uganda: a cluster randomized trial.

本文引用的文献

1
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.降压治疗对 2 型糖尿病与非 2 型糖尿病患者主要心血管疾病预防的影响:一项个体参与者水平数据的荟萃分析。
Lancet Diabetes Endocrinol. 2022 Sep;10(9):645-654. doi: 10.1016/S2213-8587(22)00172-3. Epub 2022 Jul 22.
2
Targeted-BEHRT: Deep Learning for Observational Causal Inference on Longitudinal Electronic Health Records.基于深度学习的纵向电子健康记录观察性因果推断的靶向 BEHRT。
IEEE Trans Neural Netw Learn Syst. 2024 Apr;35(4):5027-5038. doi: 10.1109/TNNLS.2022.3183864. Epub 2024 Apr 4.
3
乌干达2型糖尿病患者中护士主导的管理干预对收缩压的有效性:一项整群随机试验
Clin Diabetes Endocrinol. 2024 May 20;10(1):16. doi: 10.1186/s40842-024-00173-w.
4
Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.基于钠的对乙酰氨基酚:对血压、心血管事件和全因死亡率的影响。
Eur Heart J. 2023 Nov 7;44(42):4448-4457. doi: 10.1093/eurheartj/ehad535.
5
Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk.收缩压、慢性阻塞性肺疾病与心血管风险。
Heart. 2023 Jul 27;109(16):1216-1222. doi: 10.1136/heartjnl-2023-322431.
An Explainable Transformer-Based Deep Learning Model for the Prediction of Incident Heart Failure.
基于可解释的 Transformer 的深度学习模型预测心力衰竭事件。
IEEE J Biomed Health Inform. 2022 Jul;26(7):3362-3372. doi: 10.1109/JBHI.2022.3148820. Epub 2022 Jul 1.
4
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.降压与新发 2 型糖尿病风险:一项个体参与者数据荟萃分析。
Lancet. 2021 Nov 13;398(10313):1803-1810. doi: 10.1016/S0140-6736(21)01920-6.
5
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.降压药物治疗预防心血管疾病和死亡的年龄分层和血压分层效应:一项个体参与者水平数据的荟萃分析。
Lancet. 2021 Sep 18;398(10305):1053-1064. doi: 10.1016/S0140-6736(21)01921-8. Epub 2021 Aug 27.
6
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.降压药物治疗用于不同血压水平的心血管疾病一级和二级预防:一项个体参与者水平数据的荟萃分析。
Lancet. 2021 May 1;397(10285):1625-1636. doi: 10.1016/S0140-6736(21)00590-0.
7
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom.在英国的临床实践研究数据库中验证心血管结局和风险因素。
Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):237-247. doi: 10.1002/pds.5150. Epub 2020 Oct 28.
8
BEHRT: Transformer for Electronic Health Records.BEHRT:电子健康记录的转换器。
Sci Rep. 2020 Apr 28;10(1):7155. doi: 10.1038/s41598-020-62922-y.
9
UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER.英国表型组学平台用于开发和验证电子健康记录表型:CALIBER。
J Am Med Inform Assoc. 2019 Dec 1;26(12):1545-1559. doi: 10.1093/jamia/ocz105.
10
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.